Filing Details

Accession Number:
0001415889-24-019147
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-07-03 14:42:03
Reporting Period:
2024-07-01
Accepted Time:
2024-07-03 14:42:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1768446 Eliem Therapeutics Inc. ELYM Pharmaceutical Preparations (2834) 832273741
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1868517 Valerie Morisset C/O Eliem Therapeutics, Inc.
Wilmington DE 19808
Evp, R&D And Cso No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-07-01 7,649 $0.00 512,956 No 4 M Direct
Common Stock Disposition 2024-07-03 50,000 $6.76 462,956 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2024-07-01 7,649 $0.00 7,649 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
10,198 2031-02-25 No 4 M Direct
Footnotes
  1. The shares subject to this option shall vest at a rate of 12/48ths of the total number of shares on the one-year anniversary of February 26, 2021 (the "February 2021 Vesting Commencement Date") and 1/48thof the total number of shares each monthly anniversary of the February 2021 Vesting Commencement Date thereafter (or if there is no corresponding day, on the last day of the month) for so long as the Reporting Person remains an officer, director, employee, consultant and/or advisor of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the February 2021Vesting Commencement Date.